• MK-0812 Workflow for CCR2 Studies in MASH

  2026-08-24

  Build a rigorous CCR2 blockade workflow around MK-0812 to distinguish monocyte recruitment from gut-barrier, microbiota, and lipid-signaling effects in MASH models. The approach combines whole-blood pharmacology, flow cytometry, tissue endpoints, and gut–liver-axis controls for more interpretable inflammation studies.

• CCK-8, Endogenous Opioids, and Morphine Withdrawal Anxiety

  2026-08-24

  This 2014 Neuroscience study identifies a previously underdefined role for cholecystokinin octapeptide (CCK-8) in reducing anxiety-like behavior during morphine withdrawal. Pharmacological blockade experiments indicate that the effect depends on central CCK1 receptor activity and endogenous μ-opioid signaling, highlighting a mechanistic direction for opioid addiction and withdrawal studies.

• 2X Taq PCR Master Mix for Reliable DNA Amplification

  2026-08-23

  2X Taq PCR Master Mix (with dye) combines recombinant Taq DNA polymerase with integrated gel-loading dye for streamlined polymerase chain reaction workflows. Its adenine-overhang chemistry supports TA cloning, while the formulation is designed for routine genotyping, cloning, and DNA sequence analysis.

• Candida auris Antifungal Pipeline: Systematic Review

  2026-08-22

  This systematic review maps 12 investigational antifungals against multidrug-resistant Candida auris, integrating susceptibility data with evidence from neutropenic animal models. Its main practical contribution is a structured comparison of emerging agents while showing why promising MIC values and survival benefits still require validation in standardized studies and clinical populations.

• Ribonuclease R Workflow for Circular RNA in Pulpitis

  2026-08-21

  Use Ribonuclease R to reduce linear-RNA background and strengthen circular RNA validation in inflammation and DNA-damage studies. This workflow connects RNase R-resistant transcript enrichment with qRT-PCR, localization, pulldown, and pathway assays inspired by recent pulpitis research.

• Pterostilbene Preserves Mitochondrial Quality in Dermal Agin

  2026-08-21

  Zhou et al. show that pterostilbene reduces senescence phenotypes in human dermal fibroblasts exposed to UVB-associated oxidative stress or replicative aging. The study links these effects to improved mitochondrial morphology, respiration, and mitophagy, while mouse experiments provide preliminary tissue-level support for a mitochondrial quality-control mechanism in skin aging.

• AMG 9810: TRPV1 Signaling Under Stress

  2026-08-20

  A translational framework for using AMG 9810 to dissect TRPV1-dependent sensory signaling while incorporating metabolic and lysosomal stress as experimental context rather than assumed mechanism.

• MK-0812 and the Gut–Liver Inflammation Axis

  2026-08-20

  A translational framework for using MK-0812 to test whether CCR2-dependent monocyte trafficking connects intestinal TM6SF2 loss, gut–liver signaling, and MASH-associated inflammation.

• Cdc42–GSK-3β/β-Catenin Signaling in Kidney Fibrosis

  2026-08-19

  The 2024 Advanced Science study identified daphnepedunin A, a natural diterpenoid from Wikstroemia chamaedaphne, as an anti-fibrotic lead that directly targets Cdc42. By reducing Cdc42 activity and disrupting the PKCζ/GSK-3β/β-catenin axis, the compound promoted β-catenin degradation and attenuated renal fibrosis in cell and unilateral ureteral obstruction models.

• Influenza Hemagglutinin (HA) Peptide in EV Assays

  2026-08-19

  Influenza Hemagglutinin (HA) Peptide is more than a detection reagent: it can be used to design cleaner capture, competition, and elution experiments. This guide connects HA-tag workflow decisions with mechanistic lessons from RAB31-controlled exosome biology.

• Intestinal TM6SF2 and the Gut–Liver Axis in MASH

  2026-08-18

  The 2025 Nature Metabolism study identifies intestinal TM6SF2 as a protective regulator of the gut–liver axis, linking epithelial lipid handling to barrier integrity, microbial dysbiosis, lysophosphatidic acid signaling and MASH. Its conditional knockout, fecal-transfer, co-housing and pharmacological experiments provide a framework for distinguishing intestine-initiated mechanisms from liver-intrinsic disease processes.

• Angiotensin II: From GPCR Signal to AAA Strategy

  2026-08-18

  A translational framework for using Angiotensin II as a mechanistically defined vascular stressor, connecting receptor signaling and oxidative stress to hypertension, remodeling, and abdominal aortic aneurysm research while clarifying how targeted delivery strategies may improve therapeutic translation.

• Naloxone Hydrochloride for Cell Assay Reliability

  2026-08-17

  Learn how Naloxone hydrochloride, SKU B8208, can support controlled cell viability, proliferation, and cytotoxicity experiments through defined receptor biology, practical solubility, and documented purity. This scenario-based guide addresses stock preparation, assay controls, interpretation, and evidence-based product selection.

• TPPU and the sEH–Nrf2 Translational Axis

  2026-08-17

  TPPU offers a precise way to interrogate soluble epoxide hydrolase, fatty acid epoxide signaling, inflammatory pain, and the emerging hepatic sEH–Nrf2–osteoclastogenesis axis.

• Pazopanib: Genotype-Aware RTK Assay Design

  2026-08-16

  Pazopanib and GW-786034 offer a powerful framework for studying angiogenesis inhibition and tumor growth suppression. This article explains how ATRX status, pathway-resolved readouts, and combination-assay design can make pazopanib cancer research more informative.

8064 records 1/538 page Next 12345 下5页 Last page